Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TT-01688-CL in Moderate-to-Severe Atopic Dermatitis
CTR20221555Phase 2Completed
- Sponsor
- TransThera Biosciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zectivimod in atopic dermatitis (AD), sponsored by TransThera Biosciences. Started Jun 2022; status: completed.
02
Drugs
zectivimod
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20221555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221555.